These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8217269)

  • 41. Otic capsule bony lesions in the Palmerston North autoimmune mouse.
    Hertler CK; Trune DR
    Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):713-8. PubMed ID: 2126093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Otosclerosis: a perilabyrinthine threshold phenomenon.
    Bloch SL; Sørensen MS
    Acta Otolaryngol; 2012 Apr; 132(4):344-8. PubMed ID: 22217131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction.
    Gopinath B; Adams CL; Musselman R; Tani J; Wall JR
    Ocul Immunol Inflamm; 2007; 15(2):81-8. PubMed ID: 17558832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases.
    Cook AD; Mackay IR; Cicuttini FM; Rowley MJ
    J Rheumatol; 1997 Nov; 24(11):2090-6. PubMed ID: 9375865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Anti-type II collagen antibodies in collagen disease].
    Fukasawa Y; Kano S
    Rinsho Byori; 1993 Aug; 41(8):876-81. PubMed ID: 8371503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis.
    Koivula MK; Aman S; Alasaarela E; Karjalainen A; Hakala M; Risteli J
    Rheumatology (Oxford); 2006 Nov; 45(11):1364-9. PubMed ID: 16632481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum antibodies against intact human collagen IX are elevated at onset of rheumatoid arthritis but are not related to development of erosions.
    Jäälinoja J; Nissilä M; Kauppi MJ; Hakala M; Laiho K; Karttunen R; Hörkkö S; Ala-Kokko L
    J Rheumatol; 2008 May; 35(5):745-51. PubMed ID: 18381798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measles virus in otosclerosis and the specific immune response of the inner ear.
    Arnold W; Niedermeyer HP; Lehn N; Neubert W; Höfler H
    Acta Otolaryngol; 1996 Sep; 116(5):705-9. PubMed ID: 8908246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis.
    Morgan K; Clague RB; Collins I; Ayad S; Phinn SD; Holt PJ
    Ann Rheum Dis; 1987 Dec; 46(12):902-7. PubMed ID: 3426299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunological cross reactivity between Candida albicans and human tissue.
    Vojdani A; Rahimian P; Kalhor H; Mordechai E
    J Clin Lab Immunol; 1996; 48(1):1-15. PubMed ID: 10332630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The presence of antinuclear antibodies in the blood and damage to the inner ear in patients with otosclerosis].
    Savić D; Jesić S; Mircetić V; Djerić D
    Srp Arh Celok Lek; 1986 Feb; 114(2):155-60. PubMed ID: 3487839
    [No Abstract]   [Full Text] [Related]  

  • 52. Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels.
    Kuivaniemi H; Tromp G; Prockop DJ
    Hum Mutat; 1997; 9(4):300-15. PubMed ID: 9101290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Deafness and autoimmunity].
    Amsallem P; Andrieu-Guitrancourt J; Dehesdin D
    Ann Otolaryngol Chir Cervicofac; 1985; 102(5):345-50. PubMed ID: 4037621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated autoantibodies in sera from otosclerotic patients are related to the disease duration.
    Lolov SR; Edrev GE; Kyurkchiev SD; Kehayov IR
    Acta Otolaryngol; 1998 Jun; 118(3):375-80. PubMed ID: 9655212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibodies against a 30 kilodalton cochlear protein and type II and IX collagens in the serum of patients with inner ear diseases.
    Joliat T; Seyer J; Bernstein J; Krug M; Ye XJ; Cho JS; Fujiyoshi T; Yoo TJ
    Ann Otol Rhinol Laryngol; 1992 Dec; 101(12):1000-6. PubMed ID: 1463290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Development of the bony capsule of the labyrinth in the human inner ear during the prenatal period (data towards the study of the etiology and pathogenesis of otosclerosis)].
    Belousova AA
    Zh Ushn Nos Gorl Bolezn; 1970; 30(1):20-6. PubMed ID: 5463747
    [No Abstract]   [Full Text] [Related]  

  • 57. Altered immunoregulations in otosclerosis: presence of autoantibodies in otosclerotic sera samples.
    Jesić S; Radulović R; Arsović N
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S50-2. PubMed ID: 9065626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of collagens in the otosclerotic bone.
    Niedermeyer HP; Becker ET; Arnold W
    Adv Otorhinolaryngol; 2007; 65():45-49. PubMed ID: 17245021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study of immune reactions to collagen in patients with myopia].
    Lazuk AV; Slepova OS
    Vestn Oftalmol; 1995; 111(2):14-6. PubMed ID: 7645169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunohistochemical localization of collagenous proteins in cartilaginous tumors: characteristic distribution of type IX collagen.
    Kawashima A; Ueda Y; Tsuchiya H; Tomita K; Nagai Y; Nakanishi I
    J Cancer Res Clin Oncol; 1993; 120(1-2):35-40. PubMed ID: 8270606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.